Collaboration Product Development Clause Samples
The Collaboration Product Development clause establishes the framework for two or more parties to jointly develop a new product or technology. It typically outlines the roles and responsibilities of each party, the process for sharing resources and information, and the management of intellectual property created during the collaboration. This clause ensures that all parties have a clear understanding of their contributions and rights, thereby minimizing disputes and facilitating efficient, cooperative product development.
POPULAR SAMPLE Copied 1 times
Collaboration Product Development. Subject to Article 9 if the --------------------------------- Parties Co-Promote, Warner shall be responsible for all costs of conducting Development of Collaboration Product(s) in [*] CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. -28- the Territory, including, without limitation, expenses incurred in conducting clinical trials for Collaboration Products for which it retains commercialization rights thereto. In addition, Warner shall be responsible, at its sole expense, for all commercialization of such Collaboration Product(s) in the Territory so long as Warner retains rights thereto under this Agreement. During the term of this Agreement, Warner shall keep GenVec fully informed of its activities subject to this Agreement, including without limitation, the achievement of the milestones set forth in Sections 6.4 and 8.2.2 and the commercialization of the Collaboration Product(s). On or before January 31 of each year, at GenVec's request, Warner shall provide GenVec with a written report summarizing such events and activities and detailing those which have not been previously reported. When a registration package requesting approval for commercial sale of any Collaboration Product is first filed in any country within the Territory, and when approval is received therefor, Warner will immediately notify GenVec in writing.
Collaboration Product Development. Subject to Article 9 if the Parties Co-Promote, Warner shall be responsible for all costs of conducting Development of Collaboration Product(s) in the Territory, including, without limitation, expenses incurred in conducting clinical trials for Collaboration Products for which it retains commercialization rights thereto. In addition, Warner shall be responsible, at its sole expense, for all commercialization of such Collaboration Product(s) in the Territory so long as Warner retains rights thereto under this Agreement. During the term of this Agreement, Warner shall keep GenVec fully informed of its activities subject to this Agreement, including without limitation, the achievement of the milestones set forth in Sections 6.4 and 8.2.2 and the commercialization of the Collaboration Product(s). On or before January 31 of each year, at GenVec's request, Warner shall provide GenVec with a written report summarizing such events and activities and detailing those which have not been previously reported. When a registration package requesting approval for commercial sale of any Collaboration Product is first filed in any country within the Territory, and when approval is received therefor, Warner will immediately notify GenVec in writing.
Collaboration Product Development. At the end of Collaboration Stage 1, and on a Collaboration Product-by-Collaboration Product basis, the Parties will meet, through the JRC, to discuss the further development and commercialization of such Collaboration Product. At such time, and subject to the principles set forth below in Sections 4.1.1 through 4.1.4, the Parties shall, within sixty (60) days of the end of Collaboration Stage 1 (the “Election Period”), elect to (i) negotiate and enter into a definitive co-development agreement for such Collaboration Product, (ii) negotiate and enter into a definitive license agreement where one Party (the “Developing Party”) is responsible for the development of such Collaboration Product, or (iii) seek a third party to develop such Collaboration Product.